| Edward Branson, NP | |
|
398 Neponset Ave, Dorchester, MA 02122-3134 | |
| (617) 282-3200 | |
| (617) 282-8201 |
| Full Name | Edward Branson |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Location | 398 Neponset Ave, Dorchester, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215912001 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 153494 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Edward Branson, NP 1135 Morton St, Mattapan, MA 02126-2834 Ph: (617) 533-2300 | Edward Branson, NP 398 Neponset Ave, Dorchester, MA 02122-3134 Ph: (617) 282-3200 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of a Phase I/IIa clinical trial of IL-7 in support of tumor lysate/KLH pulsed dendritic cell vaccines in a pilot study of tumor vaccination in patients with metastatic or recurrent pediatric solid tumors and altered T cell homeostasis, including patients with Ewing's sarcoma family of tumors (ESFT), rhabdomyosarcoma, neuroblastoma, synovial cell sarcoma, desmoplastic small round cell tumor, undifferentiated sarcoma, and embryonal sarcoma.
Researchers from Boston University School of Medicine, along with clinicians from Boston Medical Center, have found gastroenterologist knowledge of the appropriate immunizations to recommend to the inflammatory bowel disease patient is limited.
A majority of Michigan oncology practices participating in a statewide consortium followed treatment guidelines for common cancers, but had gaps in managing symptoms and end-of-life care, according to a new study.
While most patients and physicians believe it's important for adults to have an annual physical exam, there's growing debate about this conventional wisdom.
A candidate dengue vaccine developed by scientists at the National Institutes of Health (NIH) has been found to be safe and to stimulate a strong immune response in most vaccine recipients, according to results from an early-stage clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH. The trial results were published online on January 17 in the Journal of Infectious Diseases.
› Verified 9 days ago
Karla I Noonan, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 632 Blue Hill Ave, Dorchester, MA 02121 Phone: 617-825-3400 | |
Jocelyn Loftus, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 398 Neponset Ave, Dorchester, MA 02122 Phone: 617-282-3200 Fax: 617-282-7928 | |
Allison Foley, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 398 Neponset Ave, Dorchester, MA 02122 Phone: 617-282-3200 Fax: 617-282-8201 | |
Rachel Marino, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 425 Harvard St, Dorchester, MA 02124 Phone: 978-857-5961 | |
Ms. Denise Marie Croken, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 637 Washington St, Dorchester, MA 02124 Phone: 617-825-9660 | |
Kathleen Black Tenerowicz, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1353 Dorchester Ave, Dorchester, MA 02122 Phone: 617-288-3230 Fax: 617-825-4972 | |
Jane F Tuitt, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 637 Washington St, Dorchester, MA 02124 Phone: 617-822-8211 Fax: 617-288-7898 |